{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:14:02Z","timestamp":1754162042958,"version":"3.41.2"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The goal of this study was to evaluate the prevalence of chronic kidney disease (CKD) in young patients with acute myocardial infarction (AMI) and to report their characteristics and clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Underlying renal dysfunction is a risk factor for poor cardiovascular outcomes in older patients. The implication of CKD in young patients with AMI is not well studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a retrospective population-based cohort study of patients aged 18\u201350 who presented with AMI between 2006 and 2016. Medical records were reviewed to confirm diagnosis and to identify treatment and long-term outcomes. Cox regression models were used to evaluate the association of CKD with mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 1753 young patients with type 1 AMI (median age 45 years, 85.3% male), CKD was present in 112 (6.8%) patients. A higher proportion of CKD patients had concomitant hypertension, hyperlipidemia, diabetes, and obesity. Use of statin and P2Y12 inhibitors post-AMI was lower in CKD patients. Over a median follow-up of 7.2 years, CKD was associated with higher all-cause mortality [hazard ratio (HR), 9.3; 95% CI, 6.3\u201313.8]. This association persisted after adjusting for demographics, comorbidities, and treatment (adjusted HR, 3.6; 95% CI, 2.2\u20136.0).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Presence of CKD was associated with 3.6-fold higher mortality over a median follow-up of 7.2 years. A lower proportion of CKD patients were treated with statin therapy and P2Y12 inhibitors. These findings highlight the need for intensive risk factor modification and optimal use of guideline-directed medical therapies in this high-risk population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001179","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:01:24Z","timestamp":1660017684000},"page":"553-558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Acute myocardial infarction in young adults with chronic kidney disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Karo","family":"Gyurjian","sequence":"first","affiliation":[{"name":"Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Schweis","sequence":"additional","affiliation":[{"name":"Cardiology, Kaiser Permanente Los Angeles Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sej","family":"Patel","sequence":"additional","affiliation":[{"name":"University of California Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryant","family":"Hammershaimb","sequence":"additional","affiliation":[{"name":"Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Chiu","sequence":"additional","affiliation":[{"name":"Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Nadadur","sequence":"additional","affiliation":[{"name":"Cardiology, Kaiser Permanente Los Angeles Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sum","family":"Lee","sequence":"additional","affiliation":[{"name":"Cardiology, Kaiser Permanente Los Angeles Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2014.04.054","article-title":"Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010.","volume":"64","author":"Gupta","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.165.22.2659","article-title":"Renal function and risk of myocardial infarction in an elderly population: the Rotterdam study.","volume":"165","author":"Brugts","year":"2005","journal-title":"Arch Intern Med"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination.","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2004080656","article-title":"Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.","volume":"16","author":"Muntner","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199809173391211","article-title":"Chronic renal failure\u2013a vasculopathic state.","volume":"339","author":"Luke","year":"1998","journal-title":"N Engl J Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12882-019-1261-x","article-title":"Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function-a descriptive study.","volume":"20","author":"M\u00f6rtberg","year":"2019","journal-title":"BMC Nephrol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/2047487317693950","article-title":"Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.","volume":"24","author":"Khedri","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ahj.2005.03.033","article-title":"Impact of renal dysfunction on 1-year mortality after acute myocardial infarction.","volume":"151","author":"Schiele","year":"2006","journal-title":"Am Heart J"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2018.02.047","article-title":"Cocaine and marijuana use among young adults with myocardial infarction.","volume":"71","author":"DeFilippis","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.amjmed.2019.10.020","article-title":"Risk factors and outcomes of very young adults who experience myocardial infarction: the partners YOUNG-MI registry.","volume":"133","author":"Yang","year":"2020","journal-title":"Am J Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1077558712466293","article-title":"Race and ethnicity data quality and imputation using U.S. Census data in an integrated health system: the Kaiser Permanente Southern California experience.","volume":"70","author":"Derose","year":"2013","journal-title":"Med Care Res Rev"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0735-1097(02)02956-X","article-title":"Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb\/IIIa inhibitors.","volume":"41","author":"Freeman","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archinte.168.9.987","article-title":"Long-term prognosis of acute kidney injury after acute myocardial infarction.","volume":"168","author":"Parikh","year":"2008","journal-title":"Arch Intern Med"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","article-title":"Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.","volume":"119","author":"Han","year":"2006","journal-title":"Am J Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1681\/ASN.2016010027","article-title":"Social determinants of racial disparities in CKD.","volume":"27","author":"Norton","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2018.02.354","article-title":"CKD and ESRD in US hispanics.","volume":"73","author":"Desai","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis.","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ehjcvp\/pvaa004","article-title":"Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction.","volume":"7","author":"Trevisan","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:04:57Z","timestamp":1753812297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001179","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}